ANIXA BIOSCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.265 USD | +2.67% |
|
+5.32% | -15.85% |
| Apr. 18 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
| Mar. 12 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Chart calendar Anixa Biosciences, Inc.
0651dbfaaee.ar4YTbHzeehfAQe_nvC3RiHqm4q9HHdepULEsXhsS9M.ANxPPOa2S6UvcHTI5LjOC0uG793JQzsW9HWl5DsBA5cN0Vt6-qwNrG5pPw~6fc3a7954505292f95a889e9bcfbea1b
Upcoming events on Anixa Biosciences, Inc.
No events available
Past events on Anixa Biosciences, Inc.
| 2024-04-04 11:45 am | World Vaccine Congress |
| 2024-03-21 01:00 pm | Annual General Meeting |
| 2024-03-01 11:30 am | NeauxCancer Oncology Conference |
| 2024-01-17 12:15 pm | Sidoti Micro Cap Investor Conference |
| 2024-01-09 02:00 pm | Biotech Showcase |
| 2024-01-09 02:00 pm | JPMorgan Healthcare Conference |
| 2023-12-06 06:30 pm | Business Update Call |
| 2023-10-31 | Ovarian Cancer National Conference |
| 2023-09-28 08:00 am | Cantor Global Healthcare Conference |
| 2023-09-10 | H.C. Wainwright Global Investment Conference |
| 2023-08-28 | CAR TCR Summit |
| 2023-04-17 01:30 pm | American Association for Cancer Research Meeting - Poster Number : 3035 / 7 |
| 2023-03-09 | Q1 2023 Earnings Release (Projected) |
| 2023-03-09 01:00 pm | Annual General Meeting |
| 2023-01-09 06:30 pm | Biotech Showcase Conference |
| 2022-12-07 06:00 pm | San Antonio Breast Cancer Symposium - Poster No: OT2-10-02 |
| 2022-11-10 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract #672 |
| 2022-09-27 | American Association for Cancer Research Biennial Ovarian Cancer Research Symposium |
| 2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
| 2022-06-06 09:00 am | American Society of Clinical Oncology Meeting - Abstract #TPS1125 |
Annual results
| Fiscal Period | October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,25 0,25 0% | 0,00 0,00 - | 0,51 0,51 -0.1% | 0,00 0,00 - | 0,21 0,21 0% | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -5,12 -6,46 20.7% | -5,80 -6,40 9.28% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,9 -14,8 19.52% | -9,98 -10,5 4.77% | -13,1 -11,9 -10.77% | -13,9 -13,7 -1.03% | -11,0 -10,8 -1.86% | -14,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,8 -14,7 19.61% | -10,1 -10,4 3.29% | -13,1 -11,9 -10.72% | -13,8 -10,4 -32.78% | -9,93 -10,1 1.28% | -14,2 |
|
Net income Million USD | Released Forecast Spread | -11,6 -14,5 19.44% | -10,0 -10,3 2.98% | -13,0 -11,7 -10.33% | -13,6 -10,3 -31.87% | -9,81 -9,97 1.6% | -14,2 |
|
EPS USD | Released Forecast Spread | -0,59 -0,73 19.18% | -0,45 -0,47 4.26% | -0,45 -0,41 -9.76% | -0,45 -0,35 -30.43% | -0,32 -0,32 0% | -0,44 |
| Announcement Date | 09/01/20 | 07/01/21 | 04/01/22 | 04/01/23 | 16/01/24 | - |
Quarterly results
| Fiscal Period | October | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,21 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,59 -4,10 12.46% | -2,80 -3,90 28.28% | -3,61 -4,10 11.98% | -2,56 -3,50 26.86% | -2,84 -2,80 -1.57% | -3,05 -2,85 -7.05% | -3,61 -2,95 -22.34% | -3,65 | -3,65 | -3,65 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,59 -4,10 12.49% | -2,78 -3,90 28.85% | -3,53 -4,10 13.93% | -2,31 -3,50 34.09% | -2,55 -2,80 9% | -2,72 -2,85 4.53% | -3,29 -2,95 -11.53% | -3,65 | -3,65 | -3,65 | ||||
|
Net income Million USD | Released Forecast Spread | -3,54 -4,10 13.56% | -2,75 -3,90 29.59% | -3,48 -4,10 15.22% | -2,29 -3,50 34.63% | -2,51 -2,80 10.32% | -2,69 -2,85 5.61% | -3,26 -2,95 -10.34% | -3,65 | -3,65 | -3,65 | ||||
|
EPS USD | Released Forecast Spread | -0,13 -0,13 0% | -0,12 -0,13 7.69% | -0,09 -0,13 30.77% | -0,12 -0,11 -9.09% | -0,08 -0,16 50% | -0,07 -0,12 39.13% | -0,08 -0,09 11.11% | -0,09 -0,09 0% | -0,10 -0,09 -11.11% | -0,11 | -0,11 | -0,11 | -0,11 | -0,11 |
| Announcement Date | 11/03/22 | 10/06/22 | 09/09/22 | 04/01/23 | 17/03/23 | 14/06/23 | 06/09/23 | 16/01/24 | 12/03/24 | - | - | - | - | - |
More events
Past sector events for Anixa Biosciences, Inc.
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANIX Stock
- Calendar Anixa Biosciences, Inc.
